Wistar scientists discover a new way to boost a person's immune response to tumors

Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates.

Related Keywords

Rugang Zhang ,Sergey Karakashev ,Emily Henderson ,Cancer Immunology Research ,Ronald Caplan Cancer Center ,Microenvironment Metastasis Program ,Wistar Institute ,Metastasis Program ,Immune Response ,Ntigen ,Dancer ,Cancer Treatment ,Fell ,Chemotherapy ,Efficacy ,Genes ,Immune System ,Immunity ,Mmunology ,N Vitro ,N Vivo ,Metastasis ,Ovarian Cancer ,Mh ,Research ,Humor ,